Condition: Acute Aortic Syndrome · Aortic Dissection Type a · Sponsor: Nanjing Medical University
Systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) are the major causes of death in patients with acute aortic syndrome (AAS). Therefore, the prevention of SIRS and MODS is of great clinical value, and immunomodulatory therapy with thymosin alpha 1 may be beneficial. This study was designed to test the hypothesis that the administration of thymosin alpha 1 during the acute phase of AAS will result in a reduced incidence of SIRS and MODS.
This description comes directly from the study's public registry record.
Hong Liu, MD · 8618801281613 · DR.HONGLIU@FOXMAIL.COM
Hong-jia Zhang, MD · 8601068303105 · zhanghongjia722@ccmu.edu.cn
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, Anhui, China | Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| Nanjing First Hospital Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| Subei People's Hospital of Jiangsu Province | Yangzhou, Jiangsu, China | Recruiting |
| Qilu Hospital of Shandong University | Jinan, Shandong, China | Recruiting |
| West China Hospital of Sichuan University | Chengdu, Sichuan, China | Recruiting |
| The Friendship Hospital of Yili Kazak Autonomous Prefecture | Kazak, Xinjiang, China | Recruiting |
| The Seventh Affiliated Hospital of Xinjiang Medical University | Ürümqi, Xinjiang, China | Recruiting |
| The First Affiliated Hospital of Kunming Medical University | Kunming, Yunnan, China | Recruiting |
| Beijing Anzhen Hospital Capital Medical University | Beijing, China | Recruiting |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, China | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05339529